Xiao-Feng Jin Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

2/2017	Complete revascularization versus culprit-only revascularization in ST-segment elevation myocardial infarction and multivessel disease patients undergoing primary percutaneous coronary intervention: A meta-analysis and trial sequential analysis.
8/2012	Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Feng Jin Research Topics

Disease

3	ST Elevation Myocardial Infarction 02/2017 - 08/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2017 - 08/2012
2	Myocardial Infarction 05/2015 - 08/2012
1	Neoplasms (Cancer) 09/2017
1	Myopia 03/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2012
1	Hepatocellular Carcinoma (Hepatoma) 12/2012
1	Thrombosis (Thrombus) 08/2012
1	Ischemia 02/2009
1	Reperfusion Injury 02/2009
1	Chest Pain (Chest Pains) 11/2007

Drug/Important Bio-Agent (IBA)

3	omega-Chloroacetophenone (Mace)IBA 02/2017 - 08/2012
1	C-Reactive ProteinIBA 05/2015
1	Estrogens (Estrogen)FDA Link 03/2015
1	Sorafenib (BAY 43-9006)FDA Link 12/2012
1	MetalsIBA 08/2012
1	polydatinIBA 02/2009
1	NF-kappa B (NF-kB)IBA 02/2009
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2009
1	Inflammation MediatorsIBA 02/2009
1	Toll-Like Receptor 4IBA 02/2009
1	Nitroglycerin (Dynamite)FDA LinkGeneric 11/2007

Therapy/Procedure

3	Percutaneous Coronary Intervention 02/2017 - 08/2012
1	Endoscopes 09/2017
1	Stents 08/2012
1	Drug-Eluting Stents 08/2012